Evidence map›Paper›PMID 33264607›Full record

ArticleAmerican heart journal2021

Temporal trends in risk profiles among patients hospitalized for heart failure.

Carine E Hamo, Gregg C Fonarow, Stephen J Greene, Muthiah Vaduganathan, Clyde W Yancy, Paul Heidenreich, Di Lu, Roland A Matsouaka, Adam D DeVore, Javed Butler

Open access · greenAbstract read
In one paragraph

Article in American heart journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Analysis of COVID-19 Case Demographics and Disease Outcomes in Gary, Indiana.International journal of environmental research and public health · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Carine E HamoDivision of Cardiology, Johns Hopkins University, Baltimore, MD.
Gregg C FonarowAhmanson-UCLA Cardiomyopathy Center, Ronald Reagan UCLA Medical Center, Los Angeles, CA.
Stephen J GreeneDuke Clinical Research Institute, Durham, NC; Division of Cardiology, Duke University School of Medicine, Durham, NC.
Muthiah VaduganathanBrigham and Women's Hospital Heart & Vascular Center, Boston, MA.
Clyde W YancyDivision of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Paul HeidenreichDivision of Cardiology, Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA.
Di LuDuke Clinical Research Institute, Durham, NC.
Roland A MatsouakaDuke Clinical Research Institute, Durham, NC; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC.
Adam D DeVoreDuke Clinical Research Institute, Durham, NC; Division of Cardiology, Duke University School of Medicine, Durham, NC.
Javed ButlerUniversity of Mississippi Medical Center, Jackson, MS. Electronic address: Jbutler4@umc.edu.
Duke University · USBrigham and Women's Hospital · USClinical Research Institute · USJackson Memorial Hospital · USJohns Hopkins University · USNorthwestern University · USRonald Reagan UCLA Medical Center · USVA Palo Alto Health Care System · US

Funding

The Harvard Clinical and Translational Science CenterUL1TR002541 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2018 to 2022
$93.0M
CARDIOVASCULAR EPIDEMIOLOGY INSTITUTIONAL TRAININGT32HL007024 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Elizabeth Selvin · 1985 to 2026
$17.5M
NCATS NIH HHS UL1 TR002541NHLBI NIH HHS T32 HL007024
6 · The paper itself

Abstract

backgroundPostdischarge mortality following hospitalization for heart failure with reduced ejection fraction (HFrEF) has remained high and unchanged over the past 2 decades, despite effective therapies for HFrEF. We aimed to explore whether these patterns could in part be explained by changes in longitudinal risk profile and HF severity over time.

methodsAmong patients hospitalized for HF in the GWTG-HF registry from January 2005 to December 2018 with available data, we evaluated GWTG-HF and ADHERE risk scores, observing in-hospital mortality per-year. The risk profiles and outcomes were described overall and by subgroups based on ejection fraction (EF), diabetes mellitus (DM), sex, and age.

resultsOverall, 335,735 patients were included (50% HFrEF, 46% DM, 48% female, mean age 74 years). In-hospital mortality increased by 2.0% per year from 2005 to 2018. There was no significant change in mean GWTG-HF risk score overall or when stratified by EF groups (P = 0.46 HFrEF, p = 0.26 HF mid-range EF [HFmrEF], and P = 0.72 HF preserved EF [HFpEF]), age, sex, or presence of DM. The observed/expected ratio based on the GWTG-HF risk score was 0.93 (0.91-0.96), 0.83 (0.77-0.90), 0.92 (0.89-95) for HFrEF, HFmrEF, and HFpEF, respectively. Similar findings were seen when risk was assessed using ADHERE risk score.

conclusionsThere were no significant changes in average risk profiles among hospitalized HF patients over the study duration. These data do not support the notion that worsening risk profile explains the lack of improved outcomes despite therapeutic advances, underscoring the importance of aggressive implementation of guideline-recommended therapies and investigation of novel treatments.

Indexed as

AgedAged, 80 and overAge FactorsBlack or African AmericanBlood PressureBlood Urea NitrogenComorbidityDiabetes MellitusFemaleHeart FailureHeart RateHispanic or LatinoHospitalizationHospital MortalityHumansLogistic ModelsSodium

Identifiers

PMID33264607
PMCPMC8120737
OpenAlexW3108724752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.